Maternal use of antihypertensive drugs in early pregnancy and delivery outcome, notablythe presence of congenital heart defects in the infants

European Journal of Clinical Pharmacology

Volumn 65, Issue 6, 2009, Pages 615-625

  Lennestål, Roland ^a   Olausson, Petra Otterblad ^b   Källén, Bengt ^c  

^a UMEÅ UNIVERSITY   (Sweden)

^b CENTRE FOR EPIDEMIOLOGY   (Sweden)

^c UNIVERSITY OF LUND   (Sweden)

Author keywords

ACE inhibitors; Antihypertensives; Beta blocking agents; Cardiovascular defects; Congenital malformations; Stillbirths

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ARTICLE; CHEMICALLY INDUCED DISORDER; CLASSIFICATION; COHORT ANALYSIS; CONGENITAL HEART MALFORMATION; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; NEWBORN; PREGNANCY; PREGNANCY OUTCOME;

ANTIHYPERTENSIVE AGENTS; COHORT STUDIES; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; INFANT, NEWBORN; MATERNAL EXPOSURE; PREGNANCY; PREGNANCY OUTCOME;

EID: 68849090817     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-009-0620-0     Document Type: Article

References (19)

1. Rey E, Couturier A (1994) The prognosis of pregnancy in women with chronic hypertension. Am J Obst Gynecol 181:410-416 (Pubitemid 24279226)
2. McCowan LM, Buist RG, North RA et al (1996) Perinatal morbidity in chronic hypertension. Br J Obstet Gynecol 103:123-129 (Pubitemid 26054525)
3. Sibal BM, Caritis SN, Hauth JC et al (2000) Preterm delivery in women with pregestational diabetes or chronic hypertension relative to women with uncomplicated pregnancies. The National Institute of Child Health and Human Development - Fetal Medicine Units Network. Am J Obst Gynecol 183:1520-1524 (Pubitemid 32061218)
4. Ray JG, Burrows RF, Burrows E et al (2001) McMaster outcome study of hypertension in pregnancy. Early Hum Dev 64:129-143 (Pubitemid 32618662)
5. Abalos E, Duley L, Steyn DW et al (2007) Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database of Systematic Reviews 1: CD002252. doi:10.1002/14651858.CD002252.pub2.
6. Heinonen OP, Slone D, Shapiro S (1977) Birth defects and drugs in pregnancy. Publishing Sciences Group, Littleton, MA
7. Källén B, Otterblad Olausson P (2003) Maternal drug use in early pregnancy and infant cardiovascular defect. Reprod Toxicol 17:255-261 (Pubitemid 36626946)
8. Cooper WO, Hernandez-Diaz S, Arbogast P et al (2006) Major congenital malformations after first-trimester exposure to ACE inhibitors. New Engl J Med 354:2443-2451 (Pubitemid 43855047)
9. National Board of Health and Welfare, Centre for Epidemiology (2003) The Swedish Medical Birth Register - a summary of content and quality. http://www.sos.se/FULLTEXT/112/2003-112-3/2003-112-3.pdf. Accessed May 12, 2008
10. Källén B (1995) A birth weight for gestational age standard based on data in the Swedish Medical Birth Registry 1985-1989. Eur J Epidemiol 11:601-606
11. National Board of Health and Welfare, Centre for Epidemiology (2004) Registration of congenital malformations in Swedish health registers. http://www.socialstyrelsen.se/Publicerat/2004/5120/2004-112-1.htm. Accessed May 12, 2008
12. Källén B, Otterblad Olausson P (2001) Monitoring of maternal drug use and infant congenital malformations. Does loratadine cause hypospadias? Int J Risk Safety Med 14:115-119 (Pubitemid 35024885)
13. Åberg A, Westbom L, Källén B (2001) Congenital malformations among infants whose mothers had gestational or preexisting diabetes. Early Hum Develop 61:85-95
14. Scialli AR, Lione A (2006) ACE inhibitors and major congenital malformations (letter). New Engl J Med 355:1280 (Pubitemid 44427457)
15. Briggs GG, Freeman RK, Yaffe SJ (2005) Drugs in pregnancy and lactation, 7th edn. Lippincott Williams and Wilkins, Philadelphia
16. Barr M Jr (1994) Teratogen update: angiotensin-converting enzyme inhibitors. Teratology 50:399-409
17. Harewood WJ, Phippard AF, Duggin G et al (1994) Fetotoxicity of angiotensin-converting enzyme inhibition in primate pregnancy: a prospective, placebo-controlled study in baboons (Papio hamadryas). Am J Obstet Gynecol 171:633-642 (Pubitemid 24312341)
18. Buttar HS (1997) An overview of the influence of ACE inhibitors on fetal-placental circulation and perinatal development. Mol Cell Biochem 176:61-71
19. Tabacova S (2005) Mode of action: angiotensin-converting enzyme inhibition - developmental effects associated with exposure to ACE inhibitors. Crit Rev Toxicol 35:747-755